首页|期刊导航|中国中药杂志|中药固体制剂的晶型问题与发展前瞻

中药固体制剂的晶型问题与发展前瞻OA

Crystal form issues and development prospects of TCM solid preparations

中文摘要英文摘要

中药固体制剂作为中药临床应用的主导剂型,其质量稳定性与疗效的一致性始终是行业关注的核心议题.临床实践中发现,同一中药的不同制剂形式,甚至是不同厂家的相同制剂,往往存在一定疗效差异,这类差异的产生既与中药生产加工过程的复杂性相关,也与药物自身化学-物理状态相关,而晶型很可能是影响药物存在状态进而导致疗效偏差的重要因素.中药晶型作为中药有效成分的核心微观属性,直接决定药物物理化学性质与生物活性,是导致中药质量波动与疗效差异的根源之一.目前基于中药有效成分及其组成复方的中药晶型研究已经取得重要进展,已构建起涵盖制备、表征、特性分析的完整技术体系,其核心价值在于揭示了"成分相同但活性异质"的科学本质,有望为中药全产业链质量控制提供量化、精准的技术支撑.但传统中药复方固体制剂的晶型研究仍然是目前的重大难题,无论是中成药晶型发现、表征和优势晶型确定,还是中成药晶型的质量控制以及对临床疗效的影响,仍然是"等待耕耘的贫瘠之地".该文提出中药固体制剂的晶型问题,全面梳理中药晶型从单成分到复方制剂的全维度研究场景,系统阐释中药晶型的技术体系与类别特征,创新提出基于晶型的中药质量控制策略,可为中药固体制剂的质量控制与新型方剂纳米体药物发现提供全新研究思路,对于提升中药固体制剂的标准化水平、保障临床疗效、推动中药纳米科学发展具有重要意义.

As the dominant dosage form in clinical practice of TCM,solid preparations face core challenges concerning quality stability and consistent therapeutic efficacy.Clinical observations have revealed efficacy variations among different preparation forms of the same TCM or even among products of the same preparation from different manufacturers.Such variations are attributed not only to the complexity of the production process but also to the physicochemical states of the drug substances,among which crystal forms likely serve as a critical factor influencing the drug state and subsequent efficacy divergence.TCM crystal forms,as a fundamental microscopic attribute of active ingredients in TCM,directly determine physicochemical properties and biological activities of drugs,representing a root cause of quality fluctuation and efficacy variation.Currently,significant progress has been made in the study of TCM crystal forms based on TCM active ingredients and compound preparations.A comprehensive technical framework encompassing preparation,characterization,and property analysis has been established.Its core value lies in revealing the scientific essence of"identical composition but heterogeneous activity",and it is expected to provide quantitative and precise technical support for quality control across the entire TCM industry chain.However,research on the crystal forms of TCM solid preparations remains a major challenge.Whether it concerns the discovery,characterization,and identification of preferred crystal forms in Chinese patent medicines,or the quality control of crystal forms of Chinese patent medicines and their impact on clinical efficacy,these areas remain largely unexplored territory awaiting further investigation.This article proposed the crystal form issues in TCM solid preparations.It comprehensively reviewed the research landscape of TCM crystal forms,spanning from single components to compound preparations,systematically elucidated the associated technical systems and category characteristics of TCM crystal forms,and innovatively proposed a crystal form-based strategy for quality control.This perspective provides a novel research framework for enhancing the quality control of TCM solid preparations and discovering new formula-derived nanoparticle drugs,holding significant importance for enhancing the standardization of TCM solid preparations,ensuring clinical efficacy,and advancing the development of TCM nanoscience.

华桦;纪艳玲;敖卓;赵军宁

四川省中医药转化医学中心,国家中医药管理局中药质量生物学评价重点研究室,四川省中医药管理局中药纳米科学中医药重点实验室,四川 成都 610041四川省中医药转化医学中心,国家中医药管理局中药质量生物学评价重点研究室,四川省中医药管理局中药纳米科学中医药重点实验室,四川 成都 610041国家纳米科学中心,中国科学院 纳米生物效应与安全性实验室,北京 100190四川省中医药转化医学中心,国家中医药管理局中药质量生物学评价重点研究室,四川省中医药管理局中药纳米科学中医药重点实验室,四川 成都 610041||国家纳米科学中心,中国科学院 纳米生物效应与安全性实验室,北京 100190

晶型药物中药晶型制备与表征质量控制方剂纳米体方剂纳米体药物发现中药纳米科学

crystalline drugsTCM crystal formspreparation and characterizationquality controlformula-derived nanoparticlesformula-derived nanoparticle drug discoveryTCM nanoscience

《中国中药杂志》 2026 (13)

3617-3630,14

国家自然基金委基础科学中心项目(22388101)新基石项目(NCI202318)国家纳米科学中心研究所自主部署科研类项目(E59651R1)四川省中医药管理局科学技术研究专项重大项目(25ZDAZX007)

10.19540/j.cnki.cjcmm.20260413.301

评论